I agree disaster. Im sticking with near 500 patient in trial with 250 duravr. Six months to get the required numbers then fda approval a bit over 1 year after. For that year we will be able to sell into the trial sites who will all want to use it after their experience. Maybe I'm being optimistic.
Clinical trials, page-21
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.78 |
Change
0.780(8.67%) |
Mkt cap ! $206.7M | |||
| Open | High | Low | Value | Volume |
| $9.00 | $9.83 | $8.68 | $324.0K | 35.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 970 | $9.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |